Living Cell Technologies Ltd. (AU:1AI) has released an update.
Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
Algorae Pharmaceuticals has announced promising preclinical results for its drug candidate AI-168, which showed significant cardioprotective effects, surpassing traditional beta blockers. The company is seeking patent protection for AI-168 after these successful studies, positioning the drug to potentially capture a share of the lucrative cardiovascular treatment market.
For further insights into AU:1AI stock, check out TipRanks’ Stock Analysis page.
